ID   GNS_HUMAN               Reviewed;         552 AA.
AC   P15586; B4DYH8; Q53F05;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 3.
DT   10-MAY-2017, entry version 164.
DE   RecName: Full=N-acetylglucosamine-6-sulfatase;
DE            EC=3.1.6.14;
DE   AltName: Full=Glucosamine-6-sulfatase;
DE            Short=G6S;
DE   Flags: Precursor;
GN   Name=GNS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   GLYCOSYLATION AT ASN-422.
RC   TISSUE=Endothelial cell;
RX   PubMed=1463457; DOI=10.1042/bj2880539;
RA   Robertson D.A., Freeman C., Morris C.P., Hopwood J.J.;
RT   "A cDNA clone for human glucosamine-6-sulphatase reveals differences
RT   between arylsulphatases and non-arylsulphatases.";
RL   Biochem. J. 288:539-544(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 178-552 (ISOFORM 1), AND PARTIAL PROTEIN
RP   SEQUENCE.
RX   PubMed=3196333; DOI=10.1016/S0006-291X(88)80035-4;
RA   Robertson D.A., Freeman C., Nelson P.V., Morris C.P., Hopwood J.J.;
RT   "Human glucosamine-6-sulfatase cDNA reveals homology with steroid
RT   sulfatase.";
RL   Biochem. Biophys. Res. Commun. 157:218-224(1988).
RN   [7]
RP   GLYCOSYLATION AT ASN-183 AND ASN-279.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-183; ASN-317; ASN-387 AND
RP   ASN-422.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   INVOLVEMENT IN MPS3D.
RX   PubMed=12573255; DOI=10.1016/S0888-7543(02)00014-9;
RA   Mok A., Cao H., Hegele R.A.;
RT   "Genomic basis of mucopolysaccharidosis type IIID (MIM 252940)
RT   revealed by sequencing of GNS encoding N-acetylglucosamine-6-
RT   sulfatase.";
RL   Genomics 81:1-5(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-541, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   VARIANTS MPS3D ILE-94; 304-GLU--LEU-306 DEL; ARG-340 AND GLU-418.
RX   PubMed=20232353; DOI=10.1002/humu.21234;
RA   Valstar M.J., Bertoli-Avella A.M., Wessels M.W., Ruijter G.J.G.,
RA   de Graaf B., Olmer R., Elfferich P., Neijs S., Kariminejad R.,
RA   Suheyl Ezgue F., Tokatli A., Czartoryska B., Bosschaart A.N.,
RA   van den Bos-Terpstra F., Puissant H., Buerger F., Omran H., Eckert D.,
RA   Filocamo M., Simeonov E., Willems P.J., Wevers R.A., Niermeijer M.F.,
RA   Halley D.J.J., Poorthuis B.J.H.M., van Diggelen O.P.;
RT   "Mucopolysaccharidosis type IIID: 12 new patients and 15 novel
RT   mutations.";
RL   Hum. Mutat. 31:E1348-E1360(2010).
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of the 6-sulfate groups of the N-
CC       acetyl-D-glucosamine 6-sulfate units of heparan sulfate and
CC       keratan sulfate.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};
CC   -!- INTERACTION:
CC       P16333:NCK1; NbExp=2; IntAct=EBI-1752200, EBI-389883;
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P15586-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15586-2; Sequence=VSP_056486;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: The form A (78 kDa) is processed by internal peptidase
CC       cleavage to a 32 kDa N-terminal species (form B) and a 48 kDa C-
CC       terminal species.
CC   -!- PTM: The conversion to 3-oxoalanine (also known as C-
CC       formylglycine, FGly), of a serine or cysteine residue in
CC       prokaryotes and of a cysteine residue in eukaryotes, is critical
CC       for catalytic activity. {ECO:0000250}.
CC   -!- DISEASE: Mucopolysaccharidosis 3D (MPS3D) [MIM:252940]: A form of
CC       mucopolysaccharidosis type 3, an autosomal recessive lysosomal
CC       storage disease due to impaired degradation of heparan sulfate.
CC       MPS3 is characterized by severe central nervous system
CC       degeneration, but only mild somatic disease. Onset of clinical
CC       features usually occurs between 2 and 6 years; severe neurologic
CC       degeneration occurs in most patients between 6 and 10 years of
CC       age, and death occurs typically during the second or third decade
CC       of life. {ECO:0000269|PubMed:12573255,
CC       ECO:0000269|PubMed:20232353}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the sulfatase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z12173; CAA78164.1; -; mRNA.
DR   EMBL; AK302443; BAG63740.1; -; mRNA.
DR   EMBL; AK223484; BAD97204.1; -; mRNA.
DR   EMBL; AC025262; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC012482; AAH12482.1; -; mRNA.
DR   CCDS; CCDS8970.1; -. [P15586-1]
DR   PIR; S27164; KJHUGU.
DR   RefSeq; NP_002067.1; NM_002076.3. [P15586-1]
DR   UniGene; Hs.334534; -.
DR   ProteinModelPortal; P15586; -.
DR   BioGrid; 109061; 33.
DR   IntAct; P15586; 14.
DR   STRING; 9606.ENSP00000258145; -.
DR   iPTMnet; P15586; -.
DR   PhosphoSitePlus; P15586; -.
DR   UniCarbKB; P15586; -.
DR   BioMuta; GNS; -.
DR   DMDM; 232126; -.
DR   EPD; P15586; -.
DR   MaxQB; P15586; -.
DR   PaxDb; P15586; -.
DR   PeptideAtlas; P15586; -.
DR   PRIDE; P15586; -.
DR   DNASU; 2799; -.
DR   Ensembl; ENST00000258145; ENSP00000258145; ENSG00000135677. [P15586-1]
DR   Ensembl; ENST00000542058; ENSP00000444819; ENSG00000135677. [P15586-2]
DR   GeneID; 2799; -.
DR   KEGG; hsa:2799; -.
DR   UCSC; uc001ssg.5; human. [P15586-1]
DR   CTD; 2799; -.
DR   DisGeNET; 2799; -.
DR   GeneCards; GNS; -.
DR   H-InvDB; HIX0010785; -.
DR   HGNC; HGNC:4422; GNS.
DR   HPA; CAB026011; -.
DR   HPA; HPA013695; -.
DR   HPA; HPA048508; -.
DR   MalaCards; GNS; -.
DR   MIM; 252940; phenotype.
DR   MIM; 607664; gene.
DR   neXtProt; NX_P15586; -.
DR   OpenTargets; ENSG00000135677; -.
DR   Orphanet; 79272; Sanfilippo syndrome type D.
DR   PharmGKB; PA28802; -.
DR   eggNOG; KOG3731; Eukaryota.
DR   eggNOG; COG3119; LUCA.
DR   GeneTree; ENSGT00400000022041; -.
DR   HOGENOM; HOG000169239; -.
DR   HOVERGEN; HBG005840; -.
DR   InParanoid; P15586; -.
DR   KO; K01137; -.
DR   PhylomeDB; P15586; -.
DR   TreeFam; TF313545; -.
DR   BioCyc; MetaCyc:HS06046-MONOMER; -.
DR   BRENDA; 3.1.6.14; 2681.
DR   Reactome; R-HSA-2022857; Keratan sulfate degradation.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SABIO-RK; P15586; -.
DR   ChiTaRS; GNS; human.
DR   GenomeRNAi; 2799; -.
DR   PRO; PR:P15586; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135677; -.
DR   CleanEx; HS_GNS; -.
DR   ExpressionAtlas; P15586; baseline and differential.
DR   Genevisible; P15586; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008449; F:N-acetylglucosamine-6-sulfatase activity; TAS:Reactome.
DR   GO; GO:0008484; F:sulfuric ester hydrolase activity; IDA:MGI.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; TAS:ProtInc.
DR   GO; GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   Gene3D; 3.40.720.10; -; 1.
DR   InterPro; IPR017849; Alkaline_Pase-like_a/b/a.
DR   InterPro; IPR017850; Alkaline_phosphatase_core.
DR   InterPro; IPR012251; GlcNAc_6-SO4ase.
DR   InterPro; IPR015981; GlcNAc_6-SO4ase_met.
DR   InterPro; IPR024607; Sulfatase_CS.
DR   InterPro; IPR000917; Sulfatase_N.
DR   PANTHER; PTHR43108:SF3; PTHR43108:SF3; 1.
DR   Pfam; PF00884; Sulfatase; 1.
DR   PIRSF; PIRSF036666; G6S; 1.
DR   SUPFAM; SSF53649; SSF53649; 2.
DR   PROSITE; PS00523; SULFATASE_1; 1.
DR   PROSITE; PS00149; SULFATASE_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Glycoprotein; Hydrolase;
KW   Lysosome; Metal-binding; Mucopolysaccharidosis; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal.
FT   SIGNAL        1     36
FT   CHAIN        37    552       N-acetylglucosamine-6-sulfatase.
FT                                /FTId=PRO_0000033413.
FT   METAL        55     55       Calcium. {ECO:0000250}.
FT   METAL        56     56       Calcium. {ECO:0000250}.
FT   METAL        91     91       Calcium; via 3-oxoalanine. {ECO:0000250}.
FT   METAL       326    326       Calcium. {ECO:0000250}.
FT   METAL       327    327       Calcium. {ECO:0000250}.
FT   MOD_RES      91     91       3-oxoalanine (Cys). {ECO:0000250}.
FT   MOD_RES     541    541       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    111    111       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    117    117       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    183    183       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    198    198       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    210    210       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    279    279       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519}.
FT   CARBOHYD    317    317       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    362    362       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    387    387       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    405    405       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    422    422       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:1463457,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    449    449       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    480    480       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      65     84       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056486.
FT   VARIANT      94     94       S -> I (in MPS3D).
FT                                {ECO:0000269|PubMed:20232353}.
FT                                /FTId=VAR_064070.
FT   VARIANT     304    306       Missing (in MPS3D).
FT                                {ECO:0000269|PubMed:20232353}.
FT                                /FTId=VAR_064071.
FT   VARIANT     340    340       K -> R (in MPS3D).
FT                                {ECO:0000269|PubMed:20232353}.
FT                                /FTId=VAR_064072.
FT   VARIANT     418    418       G -> E (in MPS3D).
FT                                {ECO:0000269|PubMed:20232353}.
FT                                /FTId=VAR_064073.
FT   VARIANT     550    550       H -> Q (in dbSNP:rs2230292).
FT                                /FTId=VAR_064074.
FT   CONFLICT    252    252       F -> C (in Ref. 3; BAD97204).
FT                                {ECO:0000305}.
SQ   SEQUENCE   552 AA;  62082 MW;  85094043F6E64468 CRC64;
     MRLLPLAPGR LRRGSPRHLP SCSPALLLLV LGGCLGVFGV AAGTRRPNVV LLLTDDQDEV
     LGGMTPLKKT KALIGEMGMT FSSAYVPSAL CCPSRASILT GKYPHNHHVV NNTLEGNCSS
     KSWQKIQEPN TFPAILRSMC GYQTFFAGKY LNEYGAPDAG GLEHVPLGWS YWYALEKNSK
     YYNYTLSING KARKHGENYS VDYLTDVLAN VSLDFLDYKS NFEPFFMMIA TPAPHSPWTA
     APQYQKAFQN VFAPRNKNFN IHGTNKHWLI RQAKTPMTNS SIQFLDNAFR KRWQTLLSVD
     DLVEKLVKRL EFTGELNNTY IFYTSDNGYH TGQFSLPIDK RQLYEFDIKV PLLVRGPGIK
     PNQTSKMLVA NIDLGPTILD IAGYDLNKTQ MDGMSLLPIL RGASNLTWRS DVLVEYQGEG
     RNVTDPTCPS LSPGVSQCFP DCVCEDAYNN TYACVRTMSA LWNLQYCEFD DQEVFVEVYN
     LTADPDQITN IAKTIDPELL GKMNYRLMML QSCSGPTCRT PGVFDPGYRF DPRLMFSNRG
     SVRTRRFSKH LL
//
